Contact
1 avenue de Westphalie, Futura III
78180 Montigny-le-Bretonneux
France
Business Development Specialist
About us
Croda Pharma is a leading partner for the development of excipients and the supply of high purity materials for pharmaceutical formulations. Croda Pharma’s formulation and regulation expertise enables the next generation of drug delivery systems. We offer high purity pharmaceutical excipients to enhance delivery, efficacy, and stability of actives as well as highly performing vaccine adjuvants and in-house formulation expertise to aid in navigating drug and vaccine formulation challenges. Moreover, our lipid portfolio supports the delivery of mRNA-based vaccines.
With a product profile proven to stabilise, solubilise and to deliver the most challenging of active pharmaceutical ingredients and a substantial investment in GMP and multi-site EXCiPACT accreditation, Croda Pharma demonstrates confidence in both excipient quality and supply chain security.
Business offer
- Small Molecule Delivery: Our portfolio of high purity excipient products and speciality chemistries solve formation challenges and enhance drug delivery across a variety of administration routes and dosage forms.
- Protein Delivery: Addressing the toughest challenges associated with protein-based therapies, our Super Refined range of high purity excipients ensures optimal protein stabilization for enhanced biologic drug delivery.
- Bioprocessing : we have developed a portfolio of products dedicated to the challenges of bioprocessing in USP and DSP, in particular with our flagship product Virodex, specifically designed as an alternative to the Triton X-100.
- Nucleic Acid Delivery: Croda develops innovative lipids of unparalleled purity to solve the stability and delivery issues associated with mRNA for use in vaccines and next-generation therapeutics.
- Adjuvants Systems: We enable next-generation vaccine development through a diverse portfolio of world-leading vaccine adjuvants, immunomodulators and adjuvant formulations.
- Veterinary Health: Excipient solutions that enhance palatability, efficacy, solubility and stability of actives and formulations for livestock and companion animals. Supporting small molecules and biologics, including veterinary vaccines.
- Consumer Health: We combine our technical expertise with regulatory knowledge to help our customers market innovative products with consumer relevant claims, alongside supporting formulation development challenges.
Activities
- Service
- Immunotherapy lead generation
- Pharmacology & Biological activity
- PK/PD bioavailability
- Mode of Action
- Therapeutic efficacy
- Safety
- Immunogenicity
- Hypersensitivity & allergies
- Immunotoxicology
- Specificity
- Manufacturability
- Production quality
- CMC feasibility
- Cell activation
- Avidity testing
- Cell-based activation (APCs, AAPCs)
- Antibody-based activation
- In-vivo activation (in human transgenic mouse models)
- Gene modification / Transduction
- Retroviral & lentiviral vectors
- Transposon/transposase
- CRISPR/Cas9
- Immunotherapy lead optimization
- Engineering
- Linkers
- CMC
- GLP compliance
- Cell Culture
- Media composition
- Bioproduction
- GMP compliance
- DSP (Recovery)
- Harvest
- Purification
- Formulation
- Formulation
- Dose
- Stability
- Excipients
- Adjuvants
- Sterilization
- Lyophilization
- Storage stability
- Delivery
- Route of Administration
- Bioproduction engineering
- Formulation
- Gene Delivery System
- Lipid chemical methods
- Mixed chemical methods
- Antigen identification, selection, optimization, and validation
- Antigen optimization:
- Early purification
- Early formulation
- Vaccine: antigen format platforms
- Virus-like particles (VLP) and nanoparticle-based carriers
- DNA plasmid vaccine
- mRNA vaccine
- Lipid delivery vehicle
- CMC
- GMP compliance
- Cell Culture / Fermentation
- media formulation and supply
- Formulation
- Formulation
- Adjuvants
- Stabilization
- Excipients
- Vaccines Combination
- Lyophilization
- Shipment Monitoring
- Vaccine delivery/Administration routes
- Route of Administration
- Intramuscular route
- intradermal route
- Nasal route
- Mucosal routes
- Other devices: specify
- Delivery/ Encapsulation
- Polymeric Nanoparticles
- Lipid Nanoparticles
- Nano emulsions
- Adjuvanted delivery systems
- Bioproduction GMP
- Vaccine platform type
- Virus-like particles (VLP) and nanoparticle-based carriers
- DNA plasmid vaccine
- mRNA vaccine
- Lipid delivery vehicle
